Hemin
For the given name, see Hemin (given name).
 | |
 | |
| Systematic (IUPAC) name | |
|---|---|
|
Chloro[3,7,12,17-tetramethyl-8,13-divinylporphyrin-2,18-dipropanoato(2−)]iron(III) | |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| Pregnancy category |
|
| Routes of administration | Intravenous infusion |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
16009-13-5  |
| ATC code | B06AB01 (WHO) |
| PubChem | CID 5318002 |
| ChemSpider |
21160444 |
| UNII |
743LRP9S7N |
| ChEMBL |
CHEMBL1628226  |
| Chemical data | |
| Formula | C34H32ClFeN4O4 |
| Molar mass | 651.94 g/mol |
| |
| |
| (what is this?) (verify) | |
Hemin (trade name Panhematin) is an iron-containing porphyrin.[1] More specifically, it is protoporphyrin IX containing a ferric iron ion (heme B) with a chloride ligand.
It is used in the management of porphyria attacks, particularly in acute intermittent porphyria.
It is sometimes distinguished from hematin which has a hydroxide ligand in place of the chloride. However, the terms are sometimes equated.[2]
Hematin is considered the "X factor" required for the growth of Haemophilus influenzae.[3]
See also
References
- ↑ "hemin" at Dorland's Medical Dictionary
- ↑ "hematin" at Dorland's Medical Dictionary
- ↑ Sherris, John C.; Ryan, Kenneth J.; Ray, C. L. (2004). Sherris medical microbiology: an introduction to infectious diseases. New York: McGraw-Hill. p. 395. ISBN 0-8385-8529-9.
External links
- Information from the American Porphyria Foundation, including emergency delivery information
- Hemin at RxList
- Hemin at the US National Library of Medicine Medical Subject Headings (MeSH)
This article is issued from Wikipedia - version of the Tuesday, April 05, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.